INV-084 · Money & ethics · Conflicts of interest
HHS kratom decisions and a company in which the Homeland Security Secretary holds a stake (allegation)
Stage 2 of 5: Inquiry · Letters and records requests · Last development 14 Oct 2026
Homeland Security Secretary Markwayne Mullin's financial disclosure lists a stake worth $500,001 to $1,000,000 in Botanic Tonics, a company that sells kratom products. In August 2026 Senate Finance ranking member Ron Wyden opened an investigation into the company's relationship with Health Secretary Robert F. Kennedy Jr. and Mullin, after the DEA announced plans to ban some synthetic competitors of natural-leaf kratom.
Mullin's reported contacts with health officials on kratom came while he was a senator; no record shows an act on kratom by him as Homeland Security Secretary. The account of FDA website changes rests on unnamed sources and records described by The New York Times. The company's chief executive, a private person, is not named here. Being listed is not a finding of wrongdoing.


- People
- Markwayne Mullin, Robert F. Kennedy Jr., Botanic Tonics
- Agencies
- HHS (FDA), Justice Dept (DEA), Homeland Security Dept
- Reviewed by
- Senate Finance (minority)
Follow this case
See the cases you follow, and which have news, on Following. Or get each update in a feed reader or by email: feed for this case (how).
Money involved
- $1 million Value of Mullin's stake in Botanic Tonics on his 2026 nominee disclosure, reported as a range (Other amounts, not totaled, estimate) [4]
Timeline
The DEA publishes a new notice of intent to temporarily place 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl in Schedule I above a specified threshold, based on an 8 October 2026 HHS recommendation that replaces the lower threshold HHS gave earlier; it withdraws its July 2026 notice on 7-OH the same day. The notice gives no threshold figures. [7]
Senate Finance ranking member Ron Wyden writes to HHS Secretary Kennedy and to Botanic Tonics, answers due 31 Aug: "I am opening an investigation into the kratom industry, your company's relationship with Secretaries Kennedy and Mullin". The letters say Mullin "has advocated for restrictions on kratom's synthetic competitors while holding a sizable financial stake in Botanic Tonics" and that the company has donated $1 million to MAHA PAC. The letter to Kennedy asks whether Mullin spoke with him about "removing information on kratom from federal government websites". No reply reported. [1]
The DEA announces a plan to temporarily place 7-OH products with certain concentrations, and three 7-OH derivatives, in Schedule I for two years (as described in Sen. Wyden's letter). These are synthetic competitors of natural-leaf kratom products like the company's. [1]
(Allegation, four unnamed people) The New York Times reports that Mullin, while a senator, urged health officials to remove warnings about kratom from the FDA website. Records obtained by the Times show the FDA was asked to remove links to enforcement actions against the company and others; the links were removed by the end of 2025. [6]
The Office of Government Ethics certifies Markwayne Mullin's financial disclosure as nominee for Homeland Security Secretary. It lists "Botanic Tonics LLC (wellness tonics)" valued at $500,001 to $1,000,000. His ethics agreement of the same date does not list the company among the assets he will divest. [4]
Responses
- Department of Homeland Security: Mullin "follows all ethics and conflict of interest standards and has not lobbied for any individual or company" (NYT, Jun 2026). [6]
- HHS (Emily Hilliard): The department is "solely focused on serving the American people, not advancing industry interests" (NYT, Jun 2026). [6]
- Botanic Tonics (company lawyer): The government "never sought to restrict Botanic Tonics' continued manufacture and sale of Feel Free" (NYT, Jun 2026). [6]
Who is acting on it
- Letter Sen. Ron Wyden (D-OR): Opened an investigation into the kratom industry with letters to HHS Secretary Kennedy and Botanic Tonics, asking about the company's relationship with Kennedy and Mullin; answers due 31 Aug 2026 (3 Aug 2026, No reply or result recorded yet)
Sources
- Sen. Wyden, letter to Botanic Tonics, 3 Aug 2026
- Sen. Wyden, letter to HHS Secretary Kennedy, 3 Aug 2026
- Senate Finance Committee (minority), press release, 3 Aug 2026
- Office of Government Ethics, Markwayne Mullin nominee financial disclosure (OGE 278e), Mar 2026
- Markwayne Mullin ethics agreement, 17 Mar 2026 (via NOTUS)
- The New York Times (via The Philadelphia Inquirer), 16 Jun 2026
- Federal Register, DEA notice 2026-20943, 14 Oct 2026
Cite this case
Public Trust Tracker. "HHS kratom decisions and a company in which the Homeland Security Secretary holds a stake (allegation)" (INV-084). Last updated 14 Oct 2026. https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/
Suggest a fact check